In this issue:
- Clarithromycin for early anti-inflammatory response in CAP
- Increased pertussis burden in adolescents and adults with asthma or COPD
- Predicting benefit from adjuvant corticosteroids in CAP
- 7 vs. 14 days of antibiotics for bloodstream infections
- Post-pandemic increase in invasive group A strep infections in NZ
- Vaccination disparities in high-risk US adults
- Ziresovir in hospitalised infants with RSV
- Baloxavir for preventing influenza transmission
- PASC across COVID eras
- Self-management of long COVID
Please login below to download this issue (PDF)